Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

9.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
9.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.2K
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

8.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
8.1K
Drug Distribution: Overview01:11

Drug Distribution: Overview

410
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
410
Cellular Membranes and Drug Transport01:24

Cellular Membranes and Drug Transport

1.1K
Drugs must traverse multiple biological barriers, such as multi-layered skin, single-layered intestinal epithelium, and the plasma membrane, to reach their target sites within the body. The plasma membrane, a highly structured composite of phospholipids, carbohydrates, and proteins, is the cell's protective boundary, facilitating selective substance exchange.
Phospholipids arrange themselves into a bilayer, with hydrophilic heads oriented outward and hydrophobic tails facing inward.
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring rank robustness in scored protein interaction networks.

BMC bioinformatics·2019
Same author

Networks for better drug discovery: making optimal use of existing chemical space.

Future medicinal chemistry·2018
Same author

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.

mBio·2018
Same author

Development of a Broadly Accessible Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Platform.

Journal of virology·2018
Same author

A nonparametric significance test for sampled networks.

Bioinformatics (Oxford, England)·2017
Same author

Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease.

Scientific reports·2015
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Oct 14, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.1K

Network-Driven Drug Discovery.

Jonny Wray1, Alan Whitmore2

  • 1e-therapeutics plc, Long Hanborough, UK. Jonny.Wray@etherapeutics.co.uk.

Methods in Molecular Biology (Clifton, N.J.)
|November 3, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces a network biology approach for early drug discovery, integrating computational and experimental methods to understand complex human biology and identify new disease targets and treatments.

Keywords:
Biological complexityDrug discoveryGWASHuman geneticsNetwork biologyNetwork perturbationPhenotypic assaysPhenotypic screeningStatistical network modelsSystems biologyTarget identificationTarget validation

More Related Videos

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K

Related Experiment Videos

Last Updated: Oct 14, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.1K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.8K
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.2K

Area of Science:

  • Systems Biology
  • Computational Biology
  • Drug Discovery

Background:

  • Traditional drug discovery often overlooks the intricate interactions within biological networks.
  • Understanding cellular phenotypes requires a holistic view beyond individual molecular targets.

Purpose of the Study:

  • To present a novel framework for early-stage drug discovery using network biology.
  • To bridge the gap between molecular entities and emergent cellular phenotypes.
  • To address key challenges in drug discovery, including target identification and validation.

Main Methods:

  • A combined computational and experimental approach.
  • Utilizing network biology to model molecular interactions and cellular phenotypes.
  • Data-driven elucidation of disease-implicated biological processes.
  • Leveraging human population genetics for target support.

Main Results:

  • Demonstrated application across multiple drug discovery projects.
  • Detailed validation through a COVID-19 specific discovery project.
  • Successful identification of active molecules and their mechanisms of action.

Conclusions:

  • Network biology offers a powerful paradigm for complex early-stage drug discovery.
  • This integrated approach enhances target identification, validation, and therapeutic strategy.
  • The framework is adaptable for various diseases, including infectious diseases like COVID-19.